Priveq-backed CSAM acquires division of CapMan’s Mawell

The deal sees CSAM acquire Mawell's electronic health product division which will be merged into the Norwegian company's organisation.

CapMan first backed Mawell in 2007 through an €8m investment for 42% of the company's shares. At the time of transaction, CapMan's fully diluted holding in the asset was 77.58%, though the GP was unavailable to confirm whether it would be realising any value from the sale.

CSAM's acquisition will expand the company's healthcare software portfolio across the Nordic countries and allow Mawell to focus on its consulting business.

Priveq took a minority stake in CSAM in 2014, investing through the GP's Priveq Investment Fund IV. The company's founders and management retained majority ownership in CSAM following the investment.

Company
Founded in 2001, Mawell is a provider of software for electronic patient data management in the healthcare industry.

Headquartered in Oulu, Finland, the company employs 123 people and had net revenues of €23m in 2014.

People
CSAM – Sverre Flatby (CEO).
Mawell – Torbjörn Lindh (president, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics
• Technology
• Finland
• Norway
• Priveq Partners
• CapMan